JNJBearish (ASignal Rank 4/4)

ASignal's 10+ AI agent pipeline rates JNJ as Bearish with 79% confidence in the Healthcare sector.

AI Analysis Summary

Johnson & Johnson (JNJ) presents significant downside risk due to overvaluation, high leverage, and deteriorating earnings, despite defensive characteristics.

Investment Framework Assessment

Evaluated through three legendary investor frameworks:

  • Warren Buffett (Value Investing): Grade D — 25/100
  • Bill Ackman (Activist Investing): Grade C — 58/100
  • Ray Dalio (Macro/Risk Parity): Grade C — 55/100

Consensus: Bearish

Price Intelligence

  • Current price: $227.50
  • Price target: $197.00 (-13.4%)
  • Risk level: high
  • Horizon: medium term

Quality Assessment

  • Balance sheet: concerning
  • Cash flow: fair
  • Competitive moat: brand power

Peer Group Analysis

JNJ is in the “Oversold & Compressed” cluster alongside ZBH, XOM, WFC, WDAY, VLO (128 stocks total). 0 of 128 peers are currently bullish.

JNJ Bearish Signal — AI Analysis | ASignal